# K093940: Advocate Redi-Code Dash Blood Glucose Monitoring System Model TD-4276

- Pathway: 510(k) (Special)
- Applicant: Taidoc Technology Corporation
- Decided: Apr 23, 2010 after 122 days
- Product code: NBW (System, Test, Blood Glucose, Over The Counter)
- Device class: 2
- Regulation: 21 CFR 862.1345
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 1 generation back to K072039 (2007). 1 ancestor in all.
No later device cites it as a predicate yet.
0 of 2 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K072039: Advocate Redi-Code Blood Glucose Monitoring System, Models TD-4223E; TD-4223F, Taidoc Technology Corporation (2007) Summary page 2.

## Indications for use
ADVOCATE REDI-CODE DASH Blood Glucose Monitoring System, Model TD-4276, is intended for use in the quantitative measurement of glucose in fresh capillary whole blood from the finger and from the following alternative sites: the palm, forearm, upper-arm, calf and thigh. It is intended for use by healthcare professionals and people with diabetes mellitus at home as an aid in monitoring the effectiveness of diabetes control program. The alternative site testing in the system can be used only during steady-state blood glucose conditions. The device is not to be used for the diagnosis or screening of diabetes or tested on neonates.

Source page: https://510kreport.com/device/K093940
Methodology: https://510kreport.com/methodology